Jane Street Group, LLC Essa Pharma Inc. Transaction History

Jane Street Group, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	BUY	$3.15 - $7.94 $48,976 - $123,451	15,548 Added 62.51%	40,421 $127,000
Q1 2022 May 17, 2022	BUY	$6.18 - $14.44 $153,715 - $359,166	24,873 New	24,873 $154,000
Q2 2021 Aug 16, 2021	SELL	$24.17 - $34.28 $711,782 - $1.01 Million	-29,449 Closed	0 $0
Q1 2021 May 18, 2021	BUY	$11.61 - $32.08 $341,902 - $944,723	29,449 New	29,449 $855,000

35.1M

15.8K

21K

Ticker EPIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,073,100
Market Cap $72.3M
Description
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.